Dogs wagging tails over approval of their first cancer medicine

William Atkins
Sunday, 07 June 2009 18:36

Science - Health

Mast cell tumors appear as an accumulation of modules of mast cells on the skin of dogs, which resembles tumors.

For more information on PALLADIA and the FDA announcement, please read the MSN Money article “Palladia will become available on a widespread basis in 2010.”

in the MSN Money article, George Fennell, vice president of the Companion Animal Division within Pfizer Animal Health, stated, “Pfizer Animal Health is proud to bring the first canine cancer therapy approved by the FDA to U.S. specialists, their patients and caregivers. In the weeks and months ahead,"

Fennell adds, "Pfizer will introduce PALLADIA to boarded specialists to expand the body of clinical experience with this new therapy. The experience gained during this time will enable us to support veterinarians more effectively when we make the product available for purchase in early 2010.”

For the pdf file associated with Palladia, which is provided by Pfizer, Inc, that gives specific details of the new medicine, please go to "Palliadia (toceranib phosphate) tablets."

Among the information included in the Pfizer report, is the statement: "PALLADIA tablets are indicated for the treatment of Patnaik grade II or III, recurrent, cutaneous mast cell tumors with or without regional lymph node involvement in dogs."